The drug rimonabant, can reduce bodyweight and improve control of blood glucose levels and other cardiovascular risk factors in people with type 2 diabetes, according to an Article in this week’s issue of The Lancet. The findings suggest that this drug could be used as a new approach for treatment of diabetes where other drugs have failed.Type 2 diabetes is usually diagnosed in adulthood and is treated with either dietary changes alone or drugs. [click link for full article]